ATE307589T1 - Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr - Google Patents

Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr

Info

Publication number
ATE307589T1
ATE307589T1 AT97954070T AT97954070T ATE307589T1 AT E307589 T1 ATE307589 T1 AT E307589T1 AT 97954070 T AT97954070 T AT 97954070T AT 97954070 T AT97954070 T AT 97954070T AT E307589 T1 ATE307589 T1 AT E307589T1
Authority
AT
Austria
Prior art keywords
administration
products
metabolism products
antimicrobial defense
increase antimicrobial
Prior art date
Application number
AT97954070T
Other languages
English (en)
Inventor
Marc Peters-Golden
Theodore Standiford
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE307589T1 publication Critical patent/ATE307589T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97954070T 1996-12-03 1997-12-03 Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr ATE307589T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/757,136 US5909734A (en) 1996-12-03 1996-12-03 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
PCT/US1997/022635 WO1998024397A2 (en) 1996-12-03 1997-12-03 Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

Publications (1)

Publication Number Publication Date
ATE307589T1 true ATE307589T1 (de) 2005-11-15

Family

ID=25046516

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97954070T ATE307589T1 (de) 1996-12-03 1997-12-03 Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr
AT05016311T ATE457730T1 (de) 1996-12-03 1997-12-03 Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05016311T ATE457730T1 (de) 1996-12-03 1997-12-03 Verabreichung von produkten des 5-lipoxygenase synthesewegs zur behandlung von mikrobiellen infektionen

Country Status (9)

Country Link
US (3) US5909734A (de)
EP (2) EP1602375B1 (de)
AT (2) ATE307589T1 (de)
AU (1) AU733567B2 (de)
CA (1) CA2278140C (de)
DE (2) DE69734476T2 (de)
DK (1) DK1037640T3 (de)
ES (2) ES2251748T3 (de)
WO (1) WO1998024397A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473708B2 (en) 1996-02-15 2009-01-06 Jean Gosselin Agents with leukotriene B4-like antiviral (enveloped RNA) activities
US5909734A (en) * 1996-12-03 1999-06-08 Regents Of The University Of Michigan Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense
KR100325581B1 (ko) * 1998-08-07 2002-08-24 오우택 아라키토닉산의리폭시게네이즈대사결과물질을함유하는진통제용조성물
WO2004112795A1 (en) * 2003-06-25 2004-12-29 Ltb4 Sweden Ab Ltb4 compositions for treating tract infections
WO2005102309A2 (en) * 2004-04-26 2005-11-03 Ltb4 Sweden Ab In vivo release of endogenous anti-microbial mediators by leukotriene b4 (ltb4) administration
SI1796730T1 (sl) * 2004-09-20 2010-12-31 Ltb4 Sweden Ab Stabilizirana leukotriene b4 (ltb4) farmacevtska formulacija
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN112546196A (zh) * 2020-02-29 2021-03-26 中国人民解放军总医院第三医学中心 肌动蛋白聚合诱导剂在制备抵抗或抑制肺炎克雷伯氏菌的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4821714A (en) * 1986-12-04 1989-04-18 Smelser Danny N Pharmaceutical endotracheal tube
US5314918A (en) * 1987-06-24 1994-05-24 Smithkline Beecham Corporation Leukotriene antagonists
US5145861A (en) * 1987-11-04 1992-09-08 Merrell Dow Pharmaceuticals Inc. Fluorinated arachidonic acid derivatives
WO1993018061A1 (en) * 1992-03-07 1993-09-16 Morinaga Milk Industry Co., Ltd. Immunostimulatory agent
US5674483A (en) * 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5789441A (en) * 1996-02-15 1998-08-04 Virocell Inc. Leukotriene B4 as an antiviral and anti-neoplastic agent
US5909734A (en) * 1996-12-03 1999-06-08 Regents Of The University Of Michigan Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense

Also Published As

Publication number Publication date
DK1037640T3 (da) 2006-03-13
CA2278140A1 (en) 1998-06-11
CA2278140C (en) 2008-02-05
WO1998024397A3 (en) 1998-09-03
DE69739775D1 (de) 2010-04-01
WO1998024397A2 (en) 1998-06-11
ES2251748T3 (es) 2006-05-01
DE69734476D1 (de) 2005-12-01
AU5794298A (en) 1998-06-29
ES2341255T3 (es) 2010-06-17
US7696148B1 (en) 2010-04-13
EP1037640A2 (de) 2000-09-27
EP1602375B1 (de) 2010-02-17
US5909734A (en) 1999-06-08
US20050267211A1 (en) 2005-12-01
EP1602375A2 (de) 2005-12-07
EP1037640A4 (de) 2003-07-23
EP1602375A3 (de) 2005-12-14
DE69734476T2 (de) 2006-07-13
EP1037640B1 (de) 2005-10-26
ATE457730T1 (de) 2010-03-15
AU733567B2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
HK1014155A1 (en) Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
NZ514260A (en) A composition comprising Group C streptococcal phage associated lysin enzyme, and the use of this composition for preventing or treating streptoccocal infections
NO991548L (no) Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer
ATE307589T1 (de) Verabreichung von produkten des 5- lipoxygenasestoffwechsels zur steigerung der antimikrobiellen abwehr
EE03597B1 (et) Farmatseutiline kompositsioon, mis sisaldab Lactobacillus plantarum'it ja arginiini
AU1794601A (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
EP1013282A3 (de) Arznei- und Nahrungsmittel enthaltend Transferrine und antibakterielle Wirkstoffe zur Förderung der Immunabwehr und zur Behandlung von Infektionen
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
ES2136206T3 (es) Composicion antibacteriana que contiene alfalactalbumina multimerica.
AU5643299A (en) Humic acid and its use in the treatment of various conditions
ATE413170T1 (de) Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
WO2002074287A3 (en) Antibacterial compositions containing of oxapenem-3-carboxylic acids and antibiotics
RU94024111A (ru) Способ профилактики кишечных инфекций
BR0318497A (pt) composto de droga antibacteriana compreendendo n-acetil-d-glucosamina
RU2003347C1 (ru) Средство дл лечени протейной инфекции
Kitahara Methods of enhancing the treatment of infections- Secrets to the selection and use of antibiotics
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.
HUP9902828A3 (en) Pharmaceutical composition for killing antibiotic-resistant gram positive bacteria and treatment of infection
RU93047438A (ru) Способ лечения гнойно-воспалительных процессов
BG49408A1 (en) Medicationad premix
AU2002246544A1 (en) Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
NZ231322A (en) Treatment of viral and/or bacterial infections

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037640

Country of ref document: EP